Vanguard Group Inc Evoke Pharma Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Evoke Pharma Inc stock. As of the latest transaction made, Vanguard Group Inc holds 29,851 shares of EVOK stock, worth $14,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,851
Previous 29,851
-0.0%
Holding current value
$14,328
Previous $31,000
41.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EVOK
# of Institutions
16Shares Held
3.16MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD847KShares$406,3500.21% of portfolio
-
Bleichroeder LP New York, NY825KShares$396,0000.16% of portfolio
-
Altium Capital Management LP New York, NY725KShares$347,9720.25% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT675KShares$324,0000.03% of portfolio
-
Geode Capital Management, LLC Boston, MA27.1KShares$12,9910.0% of portfolio
About Evoke Pharma Inc
- Ticker EVOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,343,070
- Market Cap $1.6M
- Description
- Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...